|
Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer |
Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A, Podratz KC |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A, Podratz KC. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecologic Oncology 2012; 127(1): 5-10 Indexing Status Subject indexing assigned by NLM MeSH Chemotherapy, Adjuvant; Cohort Studies; Costs and Cost Analysis; Endometrial Neoplasms /economics /mortality /surgery /therapy; Female; Humans; Lymph Node Excision /economics /methods /mortality; Lymph Nodes /pathology /surgery; Lymphatic Metastasis; Middle Aged; Morbidity; Neoplasm Recurrence, Local /pathology; Neoplasm Staging; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; United States AccessionNumber 22012033883 Date bibliographic record published 09/01/2013 |
|
|
|